Lupus (SLE): vizsgálatok itt: Bulgária
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Haskovo, Plovdiv, Sofia
- Életkor
- 5 év to 80 év
- People
- 1072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - 3. fázisTaking peoplePhase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Where
- Plovdiv, Sofia
- Életkor
- 12 év to 100 év
- People
- 550 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06133972 · EU 2023-505929-14-00 - 3. fázisTaking peopleA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Where
- Haskovo, Plovdiv, Sofiya
- Életkor
- 18 év to 75 év
- People
- 202 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07332481 · EU 2025-523871-44-00 - 3. fázisTaking peopleA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Where
- Kirdzhali, Sevlievo, Sofiya
- Életkor
- 18 év to 75 év
- People
- 202 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07355218 · EU 2025-524855-30-00 - 3. fázisTaking peopleA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Where
- Haskovo, Plovdiv, Ruse, Sofia, Sofiya, Varna
- Életkor
- 18 év to 75 év
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07438496 · EU 2025-523552-31-00 - 2. fázisNot yet taking people in BulgáriaA Trial of LAD603 in Patients with Systemic Lupus Erythematosus
- Where
- Haskovo, Plovdiv, Ruse, Sevlievo, Sofia, Sofiya
- Életkor
- 18 év and over
- People
- 20 worldwide
- Run by
- Almirall S.A.
See details and how to join2026-527200-24-00 · EU 2026-527200-24-00 - 2. fázisTaking peopleA Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Where
- Haskovo, Pleven, Plovdiv, Sofia, Sofiya
- Életkor
- 18 év to 74 év
- People
- 405 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07409181 · EU 2025-523488-39-00 - 3. fázisNot yet taking people in BulgáriaRollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.
- Where
- Sofia, Sofiya
- People
- 340 worldwide
- Run by
- AstraZeneca AB
See details and how to join2026-526419-13-00 · EU 2026-526419-13-00 - 1. fázisTaking peopleA Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Where
- Sofiya
- Életkor
- 18 év to 70 év
- People
- 24 worldwide
- Run by
- Cullinan Therapeutics Inc.
See details and how to joinNCT06613360 · EU 2024-518780-36-00 - 3. fázisCsak meghívásosA Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
- Where
- Plovdiv, Sofiya
- Életkor
- 16 év and over
- People
- 760 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT04976322 · EU 2023-506368-14-00 - 3. fázisCsak meghívásosA Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
- Where
- Plovdiv, Ruse, Sofia, Sofiya
- Életkor
- 18 év and over
- People
- 864 worldwide
- Run by
- Biogen
See details and how to joinNCT05352919 · EU 2023-505635-13-00 - 3. fázisTaking peopleEfficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-1)
- Where
- Plovdiv, Sofia, Sofiya
- Életkor
- 18 év and over
- People
- 147 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2022-500699-76-00 · EU 2022-500699-76-00 - 3. fázisCsak meghívásosLong-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
- Where
- Plovdiv, Sevlievo, Varna
- Életkor
- 18 év to 75 év
- People
- 680 worldwide
- Run by
- Viatris Innovation GmbH
See details and how to joinNCT06475742 · EU 2024-514354-67-00 - 3. fázisTaking peopleA Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Where
- Plovdiv, Sofia, Sofiya, Varna
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- Viatris Innovation GmbH
See details and how to joinNCT07201129 · EU 2025-522984-14-00 - 1. fázisTaking peopleA study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus
- Where
- Plovdiv, Sofiya
- Életkor
- 18 év and over
- People
- 11 worldwide
- Run by
- Climb Bio Inc.
See details and how to join2024-520385-57-01 · EU 2024-520385-57-01 - 1. fázisTaking peopleA Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
- Where
- Plovdiv, Sofia
- Életkor
- 18 év to 65 év
- People
- 30 worldwide
- Run by
- Climb Bio, Inc.
See details and how to joinNCT07011043